However, due to the limitation of VEGF-siRNA with sole silencing function, we postulate that ppp-RNA orchestrating RIG-I activation to VEGF-siRNA (ppp-VEGF), should be a good solution and a novel strategy for cancer therapy. The gene discussed is VEGFA; the disease is cancer.